Dogecoin Struggles as Toncoin Rises Amid Market Downturn by John Darbie 26.06.2024 "Dogecoin faces a downturn, with Toncoin surpassing it in market cap amidst a 5.83% dip. Investors brace for challenging times ...
Is the Bitcoin Bottom In? Experts Weigh in on Mt. Gox Payments by John Darbie 26.06.2024 Explore the recent ups and downs of Bitcoin's price, key factors influencing its volatility, and future market outlook in this ...
Nvidia Stock: 13% Plunge Raises Investor Caution by Lilu Anderson 26.06.2024 "Nvidia's stock plunges 13% due to profit-taking after a 700% surge; despite the dip, strong performance and new tech suggest ...
Bitcoin Prices Tumble Below $60,000 Amid Mt Gox Fears by John Darbie 25.06.2024 Bitcoin dips below $60K due to profit-taking, miner selling, and Mt. Gox repayment fears, with experts debating the long-term impact.
ResMed, Inspire Medical Drop After Lilly’s Zepbound Study by Mark Eisenberg 24.06.2024 "ResMed and Inspire Medical stocks plummet after Eli Lilly's Zepbound trial success; Citi downgrades RMD, sees market shift. Read more ...
Eurofins Scientific Stock Plummets Amid Muddy Waters Report by Mark Eisenberg 24.06.2024 Eurofins Scientific stock plunges by 20% amid Muddy Waters' short-seller allegations of complex corporate structure and questionable practices.
Bitcoin Trendline Failure: New Investment Opportunities? by John Darbie 23.06.2024 Explore Bitcoin's failing trendlines: discover the current market dip, potential opportunities, future predictions, and expert analysis for investors.
Bitcoin Plunge: Unprecedented Negative Sentiment Drives Decline by John Darbie 23.06.2024 Bitcoin battles rare FUD wave despite $64k price. Prolonged negative sentiment grips the market, with key indices showing fear and ...
Ethereum’s Gas Prices Plunge: More Affordable Than Ever by John Darbie 23.06.2024 "Ethereum's gas prices hit record lows, while Layer 2 solutions surge. Discover how these changes are making the network more ...
Lilly’s Zepbound Resolves Sleep Apnea in 52% of Patients by Mark Eisenberg 22.06.2024 Eli Lilly's Zepbound reduces sleep apnea by up to 52% in trials, showing promise beyond weight loss. FDA approval for ...